Malignant hypertension and hypertensive encephalopathy.

No abstract is available for this paper.

• Publication year

  1953

• Venue

  American Journal of Medicine

• Publication date

  1953-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9343(53)90017-5PMID 13016599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Hemodynamic Effects of Hypotensive Drugs in Man: IV. 1‐Hydrazinophthalazine

  1953cited by this paper
• The emetic properties of veratrum derivatives.

  1952cited by this paper
• Effects of veriloid on essential hypertension; a new derivative of veratrum viride.

  1951cited by this paper
• The use of purified veratrum viride alkaloids in the treatment of essential hypertension.

  1951cited by this paper
• The effects of dihydroergocornine on the cerebral circulation of patients with essential hypertension.

  1950cited by this paper
• A prolonged study of oral veratrum viride in the treatment of essential hypertension.

  1950cited by this paper
• Essential Hypertension. Therapeutic Trial of Veriloid, a New Extract of Veratrum viride. ∗

  1949cited by this paper
• The hemodynamic effects of hypotensive drugs in man; veratrum viride.

  1949cited by this paper
• THE HEMODYNAMIC EFFECTS OF HYPOTENSIVE DRUGS IN MAN. I. VERATRUM VIRIDE.

  1949cited by this paper
• Essential hypertension; laboratory studies in human beings with drugs recently introduced.

  1949cited by this paper
• Veriloid, a New Hypotensive Extract of Veratrum Viride.∗

  1949cited by this paper
• THE NITROUS OXIDE METHOD FOR THE QUANTITATIVE DETERMINATION OF CEREBRAL BLOOD FLOW IN MAN: THEORY, PROCEDURE AND NORMAL VALUES.

  1948cited by this paper
• A clinical evaluation of veratrum viride in the treatment of essential hypertension.

  1948cited by this paper
• The treatment of eclampsia and pre-eclampsia with veratrum veride and magnesium sulfate.

  1947cited by this paper
• The Pharmacological Basis of Therapeutics

  1941cited by this paper
• Veratrum viride in the treatment of eclampsia

  1935cited by this paper
• The clinical actions of veratrum

  1915cited by this paper
• ON THE ACTION OF VERATRUM VIRIDE

  1915cited by this paper
• A Treatise on Therapeutics, Comprising Materia Medica and Toxicology, with Especial Reference to the Application of the Physiological Action of Drugs to Clinical Medicine

  1883cited by this paper

• Impact of intravenous antihypertensive therapy on cerebral blood flow and neurocognition: a systematic review and meta-analysis.

  2025cites this paper
• Lassen's Cerebral Autoregulation Plot Revisited and Validated 65 Years Later: Impacts of Vasoactive Drug Treatment on Cerebral Blood Flow.

  2024cites this paper
• Influence of Changes in Blood Pressure on Cerebral Perfusion and Oxygenation

  2010cites this paper
• Value of retinal examination in hypertensive encephalopathy

  2010cites this paper
• Hypertension treatment with alkaloids of Veratrum viride and Veratrum album alone or in combination with hexamethonium salts.

  2009cites this paper
• Arterial hypotension and its consequences for the cerebral circulation.

  2009cites this paper
• Acute cerebral infarct. Extracerebral genesis with particular reference to cardiovascular status.

  2009cites this paper
• 2007 Guidelines for the Management of Arterial Hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European

  2007cites this paper
• Arteriyel Hipertansiyon Tedavisi 2007 K›lavuzu Avrupa Hipertansiyon Dernei (ESH) ve Avrupa Kardiyoloji Dernei (ESC) Arteriyel Hipertansiyon Tedavisi Görev Grubu

  2007cites this paper
• Epidemiology and pathophysiology of malignant hypertension

  2007cites this paper
• Grupa Zadaniowa European Society of Hypertension (ESH) i European Society of Cardiology (ESC) ds. leczenia nadciśnienia tętniczego

  2007cites this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cites this paper
• 2013 ESH/ESC Guidelines for the management of arterial hypertension

  2007cites this paper
• 2007 ESH‐ESC Guidelines for the management of arterial hypertension

  2007cites this paper
• Ethnic disparities in the incidence, presentation and complications of malignant hypertension

  2006cites this paper
• Der Einfluß gefäßaktiver sympathicolytischer Medikamente auf die Hämodynamik und den Sauerstoffverbrauch des Gehirns bei cerebrovasculären Erkrankungen

  2004cites this paper
• Cerebrospinal fluid lactate and pyruvate concentrations in patients with malignant hypertension

  2004cites this paper
• ACUTE ABDOMINAL SYMPTOMS IN MALIGNANT HYPERTENSION: CLINICAL PRESENTATION IN FIVE CASES

  2001cites this paper
• Management of patients with myocardial infarction and hypertension.

  2000cites this paper
• Low protein diet exacerbates NO synthase inhibitor-induced hypertension in rats

  1999cites this paper
• Do patients with de novo hypertension differ from patients with previously known hypertension when malignant phase hypertension occurs?

  1999cites this paper
• What goes up, must come down: treating the hypertensive emergency

  1998cites this paper
• Does renal function improve after diagnosis of malignant phase hypertension?

  1997cites this paper
• Cerebral oxidative metabolism in essential hypertension: a meta-analysis

  1995cites this paper
• Cerebral blood flow autoregulation and hypertension.

  1985cites this paper
• Cerebral Circulation

  1983cites this paper
• Influence of respiratory stress and hypertension upon the blood-brain barrier.

  1980cites this paper
• Computerized tomographic appearance of hypertensive encephalopathy.

  1980cites this paper
• [Therapy of inadequate cerebral circulation].

  1976cites this paper
• [Brain circulation and brain metabolism (methods, physiology, physiopathology, changes in organic brain diseases, pharmacology)].

  1976cites this paper
• Methods for measurement of the cerebral blood flow.

  1974cites this paper
• Hypertensive encephalopathy: Mechanisms, clinical features, and treatment.

  1974cites this paper
• Quantitative evaluation of normal and pathologic cerebral blood flow regulation to perfusion pressure. Changes in man.

  1973cites this paper
• The blood-brain barrier to proteins under normal and pathological conditions.

  1970cites this paper
• Autoregulation of Cerebral Blood Flow: Studies During Drug‐Induced Hypertension in Normal Subjects and in Patients with Cerebral Vascular Diseases

  1968cites this paper
• Durchblutung und Sauerstoffaufnahme des Gehirns

  1968cites this paper
• Electron microscopic study of experimental acute hypertensive encephalopathy

  1968cites this paper
• Autoregulation of cerebral blood flow: influence of the arterial blood pressure on the blood flow through the cerebral cortex.

  1966cites this paper
• PHYSIOLOGY OF CEREBRAL BLOODFLOW.

  1965cites this paper
• HYPERTENSIVE ENCEPHALOPATHY.

  1965cites this paper
• Effects of protoveratrine on coronary blood flow of the renal hypertensive dog.

  1963cites this paper
• Clinical Evaluation of Protoveratrine a Used Alone and in Combination with Diuretic Agents

  1962cites this paper
• Hirndurchblutung und vegetative Anfälle

  1962cites this paper
• Hemodynamic alterations accompanying diastolic hypertension.

  1962cites this paper
• Hypertension and its relation to the nervous system.

  1961cites this paper
• Studies of internal jugular blood in cerebrovascular disease

  1961cites this paper
• Cerebral blood flow and oxygen consumption in man.

  1959cites this paper
• [Effect of vaso-active sympathicolytic agents on hemodynamics and oxygen consumption of the brain in cerebrovascular diseases; estimation with the nitrous oxide method in acute and chronic experiment].

  1959cites this paper
• A critical review of circulatory physiology as it applies to cerebral vascular disease.

  1958cites this paper
• The management of moderately severe hypertension with cryptenamine and rauwolfia; observations in patients treated for up to two years.

  1958cites this paper
• The Clinical Evaluation and Management of Hypertension §

  1955cites this paper
• Cerebral hemodynamics in patients with heart failure associated and hypertension and the response to treatment.

  1955cites this paper
• Parenteral reserpine in treatment of hypertensive emergencies.

  1955cites this paper
• Effect of increased jugular pressure on cerebral hemodynamics.

  1954cites this paper
• A clinical evaluation of oral veriloid in the treatment of hypertensive disease.

  1954cites this paper
• Cerebral hemodynamics during controlled hypotension induced by the continuous infusion of ganglionic blocking agents (hexamethonium, pendiomide and arfonad).

  1954cites this paper
• Hexamethonium-its effect on glomerular filtration rate, maximal tubular function and renal excretion of electrolytes.

  1953cites this paper
• The clinical results of oral and parenteral administration of 2-(N'p-tolyl-N'-m-hydroxyphenylaminomethyl) imidazoline hydrochloride (regitine) in the treatment of hypertension and an evaluation of the cerebral hemodynamic effects.

  1953cites this paper
• Pharmacology and toxicology.

  1953cites this paper
• Hypertensive phase of acute nephritis; specific therapy with a derivative of Veratrum viride.

  1953cites this paper
• Management of acute glomerulonephritis.

  1953cites this paper
• INTRAMUSCULAR VERILOID (AQUEOUS SOLUTION)* AS A HYPOTENSIVE AGENT

  1953cites this paper